The present invention includes compositions and methods for reducing at least one of fasting blood glucose, total cholesterol, LDL cholesterol, VLDL cholesterol, a cholesterol:HDL ratio, triglycerides, or increasing a healthy microbiome comprising a synergistic amount of a fiber blend, a polyphenol blend, and a multivitamin supplement in an amount sufficient to lower at fasting blood glucose, total cholesterol, LDL cholesterol, VLDL cholesterol, a cholesterol:HDL ratio, triglycerides, or increasing a healthy microbiome.

The present invention provides feed compositions comprising a basal animal diet supplemented with direct fed microbial (DFM) and at least one of a formulated yeast, a Capsicum product, and an antimicrobial clay. The feed compositions improve growth, general health, intestinal health, and reduce microbial pathogens in non-human animals fed the feed compositions.

The present invention provides feed compositions comprising a basal animal diet supplemented with direct fed microbial (DFM) and at least one of a formulated yeast, a Capsicum product, and an antimicrobial clay. The feed compositions improve growth, general health, intestinal health, and reduce microbial pathogens in non-human animals fed the feed compositions.

The present invention provides feed compositions comprising a basal animal diet supplemented with direct fed microbial (DFM) and at least one of a formulated yeast, a Capsicum product, and an antimicrobial clay. The feed compositions improve growth, general health, intestinal health, and reduce microbial pathogens in non-human animals fed the feed compositions.

Silver and titanium oxide nanoparticles produced with Fomes fomentarius or Fomitopsis pinicola aqueous extracts and methods for treating bacterial infections or cancer using them.

Silver and titanium oxide nanoparticles produced with Fomes fomentarius or Fomitopsis pinicola aqueous extracts and methods for treating bacterial infections or cancer using them.

Oral formulations comprising at least one botanical extract of a psychotropic macrofungus and at least one mouthfeel experience enhancer are described. For example, methods and materials for preparing a dissolvable lozenge comprising a combination of psychoactive compounds such as psilocybin, psilocin, norpsilocin, baeocystin, norbaeocystin, aeruginascin, serotonin, bufotenin, β-carboline alkaloids, muscarine, muscimol, muscazone, and ibotenic acid extracted from one or more psychotropic fungi and Szechuan peppercorn or an extract thereof are provided.

Oral formulations comprising at least one botanical extract of a psychotropic macrofungus and at least one mouthfeel experience enhancer are described. For example, methods and materials for preparing a dissolvable lozenge comprising a combination of psychoactive compounds such as psilocybin, psilocin, norpsilocin, baeocystin, norbaeocystin, aeruginascin, serotonin, bufotenin, β-carboline alkaloids, muscarine, muscimol, muscazone, and ibotenic acid extracted from one or more psychotropic fungi and Szechuan peppercorn or an extract thereof are provided.

Embodiments of the disclosure concern methods and compositions of treating or preventing viral infection, including of SARS-CoV-2, for example. In specific embodiments, one or more adjuvants are delivered to an individual receiving and/or having received fibroblasts and/or fibroblast-derived exosomes. In specific cases, the adjuvants comprise particular peptides, chloroquine and/or hydroxychloroquine, and/or one or more activators of one or more toll like receptors.

Embodiments of the disclosure concern methods and compositions of treating or preventing viral infection, including of SARS-CoV-2, for example. In specific embodiments, one or more adjuvants are delivered to an individual receiving and/or having received fibroblasts and/or fibroblast-derived exosomes. In specific cases, the adjuvants comprise particular peptides, chloroquine and/or hydroxychloroquine, and/or one or more activators of one or more toll like receptors.